Clinical trial

Deciphering the Interactions Between Food Intake, Sleepiness, and Nighttime Sleep Quality in Patients With Type 1 Narcolepsy and Idiopathic Hypersomnia

NCT06484348

Study summary

ClinicalTrials.gov

Deciphering the Interactions Between Food Intake, Sleepiness, and Nighttime Sleep Quality in Patients With Type 1 Narcolepsy and Idiopathic Hypersomnia

Design: INTERVENTIONAL · Status: RECRUITING · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

BEHAVIORAL · Unmapped registry intervention Monitoring of eating behaviors Find medicine records · Find other trials using this name

BEHAVIORAL · Unmapped registry intervention Monitoring of sleep/wake rhythm Find medicine records · Find other trials using this name

BEHAVIORAL · Unmapped registry intervention Measure of nocturnal sleep parameters Find medicine records · Find other trials using this name

BEHAVIORAL · Unmapped registry intervention Measure of sleepiness Find medicine records · Find other trials using this name

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-10-16

PhaseNA

Conditions

Narcolepsy Type 1verified · MONDO: narcolepsy-cataplexy syndrome

Idiopathic Hypersomniaverified · MONDO: idiopathic hypersomnia

Interventions

Monitoring of eating behaviorsBEHAVIORAL

Monitoring of sleep/wake rhythmBEHAVIORAL

Measure of nocturnal sleep parametersBEHAVIORAL

Measure of sleepinessBEHAVIORAL

Sponsors & collaborators

Hospices Civils de Lyonlead sponsor

Mapped research locations

LyonFrance1 Clermont-FerrandFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06484348 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.